Dr. Zhang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1425 Madison Avenue
New York, NY 10029
Education & Training
- Tongji Medical UniversityClass of 1997
Certifications & Licensure
- CA State Medical License 2019 - 2025
- NY State Medical License 2019 - 2021
- American Board of Surgery Surgery
Clinical Trials
- WJMSCs Anti-inflammatory Therapy in Acute Myocardial Infarction Start of enrollment: 2020 Nov 01
Publications & Presentations
PubMed
- 12 citationsTranscriptomic Analysis of the Major Orphan Ichthyosis Subtypes Reveals Shared Immune and Barrier Signatures.Madeline Kim, Daniela Mikhaylov, Stephanie M Rangel, Ana B Pavel, Helen He
The Journal of Investigative Dermatology. 2022-09-01 - 16 citationsTranscriptomic Profiling of Tape-Strips From Moderate to Severe Atopic Dermatitis Patients Treated With Dupilumab.Daniela Mikhaylov, Ester Del Duca, Caroline Meyer Olesen, Helen He, Jianni Wu
Dermatitis. 2021-10-01 - 22 citationsImmune and barrier characterization of atopic dermatitis skin phenotype in Tanzanian patients.Claudia C.V. Lang, Yael Renert-Yuval, Ester Del Duca, Ana B. Pavel, Jianni Wu
Annals of Allergy, Asthma & Immunology. 2021-09-01
Press Mentions
- New Jersey's Covid Surge Is Worsening, but Government Says No Extra Vaccines Heading Its WayApril 1st, 2021
- N.J.’s Pandemic Response Started Strong. Why Has so Much Gone Wrong Since?March 7th, 2021
- Sinusoidal Endothelial Cell Progenitor Cells Promote Tumour Progression in Patients with Hepatocellular CarcinomaNovember 29th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: